References
- Piette EW, Werth VP. Dapsone in the management of autoimmune bullous diseases. Immunol Allergy Clin North Am 2012; 32:317–322.
- Singh S, Sethi N, Pandith S, Ramesh GS. Dapsone-induced methemoglobinemia: “Saturation gap”-The key to diagnosis. J Anaesthesiol Clin Pharmacol 2013; 30:86–88.
- Lambert M, Sonnet J, Mahieu P, Hassoun A. Delayed sulfhemoglobinemia after acute dapsone intoxication. J Toxicol Clin Toxicol 1982; 19:45–50
- Zuidema J, Hilbers-Modderman ES, Merkus FW. Clinical pharmacokinetics of dapsone. Clin Pharmacokinet 1986; 11:299–315.
- Jollow DJ, Bradshaw TP, McMillan DC. Dapsone-induced hemolyticanemia. Drug Metab Rev 1995; 27:107–124.
- Grossman S, Budinski R, Jollow D. Dapsone-induced haemolytic anemia: Role of glucose-6-phosphate dehydrogenase in the hemolytic response rate erythrocytes to N-hydroxydapsone. J Pharmacol Exp Ther 1995; 273:870–877.
- Wieringa A, Bethlehem C, Hoogendoorn M, van der Maten J, van Roon EN. Very late recovery of dapsone-induced methemoglobinemia. Clin Toxicol (Phila) 2013; 52:80–81.
- Elonen E, Neuvonen PJ, Halmekoski J, Mattila MJ. Acute dapsone intoxication: a case with prolonged symptoms. Clin Toxicol 1979; 14:79–85.
- Neuvonen PJ, Elonen E, Haapanen EJ. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med Scand 1983; 214:215–220.
- Endre ZH, Charlesworth JA, MacDonald GJ, Woodbridge L.Successful treatment of acute dapsone intoxication using charcoal hemoperfusion. Aust NZ J Med 1983; 13:509–512.
- Park KH, Kim H, Lee CC, Cha KC, Park SM, Ji HJ, et al Dapsone intoxication: clinical course and characteristics. Clin Toxicol (Phila) 2010; 48:516–521.
- Mansouri A, Nandy I. NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites. J Investig Med 1998; 46:82–86.
- Lachant NA, Tanaka KR. Case report: dapsone-associated Heinz body hemolytic anemia in a Cambodian woman with hemoglobin E trait. Am J Med Sci 1987; 294:364–368.
- Allen A, Fisher C, Premawardhena A, Bandara D, Perera A, Allen S, et al.Methemoglobinemia and ascorbate deficiency in hemoglobin E β thalassemia: metabolic and clinical implications. Blood 2012; 120:2939–2944.
- Jackson H, Bentley CR, Hingorani M, Atkinson P, Aclimandos WA, Thompson GM. Sickle retinopathy in patients with sickle trait. Eye (Lond) 1994; 9:589–593.
- Scorza M, Galeckas K. Linear IgA disease complicated by alpha thalassemia. Pediatr Dermatol 2011; 28:471–473.
- Park S-Y, Lee K-W, Kang T-S. High-dose vitamin C management in dapsone-induced methemoglobinemia. Am J Emerg Med 2014; 32:684.
- Dötsch J, Demirakca S, Cryer A, Hänze J, Kühl P, Rascher W. Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro. Intensive Care Med 1988; 24:612–615.
- Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P. Ocular findings among thalassemia patients. Am J Ophthalmol 2006; 142:704–705.
- Seo MS, Yoon KC, Park YG. Dapsone maculopathy. Korean J Ophthalmol 1997; 11:70–73.
- Kenner OJ, Holt K, Agnello R, Chester GH. Permanent retinal damage following massive dapsone overdose. Br J Ophtalmol 1980; 64:741–744.
- Hussain N, Agrawal S. Optical coherence tomographic evaluation of macular infarction following dapsone overdose. Indian J Ophthalmol 2006; 54:271–272.
- Chakrabarti M, Suresh PN, Namperumalsamy P. Bilateral macular infarction due to diaminodiphenyl sulfone (4,4’ DDS) toxicity. Retina 1999; 19:83–84.